Overview

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Collaborator:
Shionogi